RARECast

512 Folgen

1. Lessons from Pitching Venture Capitalists

   Vom: 15.11.2017
2. Health Canada Scraps Plans for Orphan Drug Framework

   Vom: 8.11.2017
3. New Investment Boosts Rare Disease Drug Accelerator

   Vom: 1.11.2017
4. Understanding Rare Disease Caregiver Needs

   Vom: 25.10.2017
5. Deriving Rare Disease Therapies from Human Plasma

   Vom: 18.10.2017
6. Learning to Live with Purpose

   Vom: 11.10.2017
7. A Mother's Race to Find a Treatment for Her Daughter's Ultra-Rare Condition

   Vom: 4.10.2017
8. Screening for Rare Diseases

   Vom: 27.9.2017
9. A Look at the Changing World of Work for People with a Chronic Illness

   Vom: 20.9.2017
10. Aligning Interests in Rare Disease Partnerships

    Vom: 13.9.2017
11. A Veteran Venture Capitalist Discusses Investing in Rare Disease Drug Development

    Vom: 6.9.2017
12. A Patient Group Crafts Guidelines for Working with Pharma

    Vom: 30.8.2017
13. Bringing Innovation to Business Models for Rare Disease Drug Development

    Vom: 23.8.2017
14. Rethinking Accessibility and Dependency

    Vom: 16.8.2017
15. How Simon Wheatcroft, Blinded by a Rare Disease, Became an Ultramarathoner

    Vom: 9.8.2017
16. Spark Hoping Its Luxturna Will Become First FDA-Approved Gene Therapy

    Vom: 2.8.2017
17. What Rare Patient-Investors Can Learn From Venture Capitalists

    Vom: 26.7.2017
18. Novel Effort Delivers Failed DMD Drug to Former Clinical Trial Participants

    Vom: 19.7.2017
19. Centogene Seeks to Deliver Diagnoses to Rare Disease Patients Early

    Vom: 12.7.2017
20. Albireo Advances Pipeline for Rare Liver and Gastrointestinal Diseases

    Vom: 5.7.2017